[Juvenile parkinsonism. 18 cases].
The accepted Juvenile Parkinson denomination includes patients who present the characteristic symptoms before 40 years old. We are reporting 18 such patients, between 15 and 34 years old, who had a follow-up between 9 to 17 years. Based on our observations and a revision of the literature, and after considering inheritance, clinical, evolutive and therapeutic outlook we were able to reach a conclusion as to the essential features of this particular form of parkinsonism. Apparently the impairment to L-Dopa therapy developed more slowly in these patients than in presenile forms and it would be related more with the duration of the illness than with that of L-Dopa therapy.
Ferreiro
J L
JL
División Neurología, Hospital de Clínicas José de San Martín, Facultad de Medicina, Universidad de Buenos Aires, Argentina.
Pugliese
M I
MI
Caride
A E
AE
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*
D007980:Levodopa
Parkinsonismo juvenil. A propósito de 18 casos.